Bristol Myers Bags RayzeBio in $4.1B Cancer Fight Pact by Mark Eisenberg 12.02.2024 Pharma giant Bristol Myers Squibb acquires RayzeBio for $4.1 billion, expanding its presence in the oncology sector and strengthening its ...
Accent Therapeutics secures J&J and BMS as new investors in $75M series C by Mark Eisenberg 23.01.2024 Pharmaceutical giants Bristol Myers Squibb and Johnson & Johnson invest in Accent Therapeutics, a leading RNA drug developer, contributing to ...